Sumitomo Mitsui Trust Holdings, Inc. Biomarin Pharmaceutical Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$142 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 456,097 shares of BMRN stock, worth $30.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

456,097

Previous 435,466 4.74%

Holding current value

$30.7 Million

Previous $35.9 Million 10.58%

% of portfolio

0.02%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$69.02 - $93.84 $1.42 Million - $1.94 Million	20,631 Added 4.74%	456,097 $32.1 Million
Q2 2024 Jul 19, 2024	SELL	$74.43 - $92.22 $3.13 Million - $3.88 Million	-42,034 Reduced 8.8%	435,466 $35.9 Million
Q1 2024 Apr 19, 2024	SELL	$83.81 - $99.0 $343,285 - $405,504	-4,096 Reduced 0.85%	477,500 $41.7 Million
Q4 2023 Jan 30, 2024	SELL	$76.22 - $98.51 $442,457 - $571,850	-5,805 Reduced 1.19%	481,596 $46.4 Million
Q3 2023 Oct 30, 2023	SELL	$85.07 - $94.48 $1.2 Million - $1.33 Million	-14,122 Reduced 2.82%	487,401 $43.1 Million
Q2 2023 Jul 31, 2023	SELL	$86.68 - $100.3 $7.14 Million - $8.26 Million	-82,377 Reduced 14.11%	501,523 $43.5 Million
Q1 2023 Apr 27, 2023	SELL	$87.74 - $117.27 $203,556 - $272,066	-2,320 Reduced 0.4%	583,900 $56.8 Million
Q4 2022 Jan 30, 2023	SELL	$80.93 - $108.63 $523,778 - $703,053	-6,472 Reduced 1.09%	586,220 $60.7 Million
Q3 2022 Oct 21, 2022	BUY	$82.16 - $96.94 $279,919 - $330,274	3,407 Added 0.58%	592,692 $50.2 Million
Q2 2022 Jul 26, 2022	BUY	$71.48 - $86.85 $1.81 Million - $2.2 Million	25,294 Added 4.48%	589,285 $48.8 Million
Q1 2022 Apr 27, 2022	BUY	$74.28 - $92.69 $22,878 - $28,548	308 Added 0.05%	563,991 $43.5 Million
Q4 2021 Feb 02, 2022	BUY	$71.72 - $91.47 $2.46 Million - $3.14 Million	34,324 Added 6.48%	563,683 $49.8 Million
Q3 2021 Oct 25, 2021	SELL	$74.77 - $85.47 $1.61 Million - $1.84 Million	-21,497 Reduced 3.9%	529,359 $40.9 Million
Q2 2021 Aug 02, 2021	SELL	$75.51 - $84.79 $2.68 Million - $3.01 Million	-35,489 Reduced 6.05%	550,856 $46 Million
Q1 2021 Apr 30, 2021	SELL	$74.73 - $90.69 $2.29 Million - $2.77 Million	-30,584 Reduced 4.96%	586,345 $44.3 Million
Q4 2020 Feb 05, 2021	SELL	$72.61 - $90.2 $25 Million - $31 Million	-343,698 Reduced 35.78%	616,929 $54.1 Million
Q3 2020 Oct 30, 2020	BUY	$71.87 - $131.03 $17.4 Million - $31.7 Million	242,035 Added 33.68%	960,627 $73.1 Million
Q2 2020 Jul 27, 2020	BUY	$79.55 - $124.22 $338,644 - $528,804	4,257 Added 0.6%	718,592 $88.6 Million
Q1 2020 Apr 27, 2020	BUY	$71.37 - $96.85 $2.24 Million - $3.04 Million	31,414 Added 4.6%	714,335 $60.4 Million
Q4 2019 Jan 31, 2020	BUY	$64.27 - $86.37 $668,279 - $898,075	10,398 Added 1.55%	682,921 $57.7 Million
Q3 2019 Oct 31, 2019	SELL	$67.4 - $85.11 $170,656 - $215,498	-2,532 Reduced 0.38%	672,523 $45.3 Million
Q2 2019 Jul 29, 2019	SELL	$80.35 - $93.9 $5.62 Million - $6.56 Million	-69,897 Reduced 9.38%	675,055 $57.8 Million
Q1 2019 May 08, 2019	BUY	$84.2 - $98.62 $5.67 Million - $6.64 Million	67,321 Added 9.93%	744,952 $66.2 Million
Q4 2018 Feb 06, 2019	BUY	$80.14 - $106.07 $8.79 Million - $11.6 Million	109,630 Added 19.3%	677,631 $56.7 Million
Q3 2018 Nov 07, 2018	BUY	$93.92 - $105.72 $1.18 Million - $1.33 Million	12,603 Added 2.27%	568,001 $55.1 Million
Q2 2018 Aug 01, 2018	BUY	$76.01 - $99.03 $4.71 Million - $6.13 Million	61,915 Added 12.55%	555,398 $52.3 Million
Q1 2018 May 01, 2018	BUY	$77.67 - $92.63 $288,854 - $344,490	3,719 Added 0.76%	493,483 $40 Million
Q4 2017 Feb 06, 2018	BUY	$80.76 - $95.13 $1.1 Million - $1.29 Million	13,598 Added 2.86%	489,764 $43.7 Million
Q3 2017 Nov 07, 2017	SELL	$80.6 - $94.95 $5.58 Million - $6.57 Million	-69,208 Reduced 12.69%	476,166 $44.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	545,374	545,374 $49.5 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Biomarin Pharmaceutical Inc Transaction History